Torok Michael has filed 5 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 19350 shares of Carisma Therapeutics Inc. ($CARM) on June 26, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2024 | Carisma Therapeutics Inc. | $CARM | Torok Michael | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Carisma Therapeutics Inc. | $CARM | Torok Michael | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Torok Michael | Director | A | Common Stock | 51250 | $0.00 | 101,250.0000 | 0 | 102.50% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Torok Michael | Director | A | Common Stock | 319991 | $0.00 | 371,241.0000 | 0 | 624.37% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Torok Michael | Director | A | Common Stock | 50000 | $0.00 | 101,250.0000 | 0 | 97.56% | 0.00% |